TOM Pharmacy
Medication management infrastructure and software for ambulatory surgery centers.
Website: https://www.tompharmacy.com/
Cover Block
From the public record
| Field | Value |
|---|---|
| Name | TOM Pharmacy |
| Tagline | Medication management infrastructure and software for ambulatory surgery centers. |
| Headquarters | Austin, United States |
| Founded | 2022 |
| Stage | Pre-Seed |
| Business Model | SaaS |
| Industry | Healthtech |
| Technology Type | Software (Non-AI) |
| Geography | North America |
| Growth Profile | Venture Scale |
| Founding Team | Solo Founder |
| Funding Label | Pre-seed |
Links
From the public record
- Website: https://www.tompharmacy.com/
- LinkedIn: https://www.linkedin.com/posts/tomrx_some-news-im-proud-to-share-tom-pharmacy-activity-7477030043676725248-rDlI
The Short Version
PUBLIC TOM Pharmacy is building medication management software for ambulatory surgery centers, a narrow but operationally important workflow where paper logs, compliance checks, and pharmacist review still appear common in the company’s own market framing, which is enough to make the category worth watching even before public traction is visible [tompharmacy.com, retrieved 2026]. The company’s public materials position the product as a pharmacist-built system for ASC medication workflows, with visible modules including a dashboard, controlled-substance log, temperature and humidity logs, a pharmacist verification queue, a compliance score, and diversion-risk monitoring [tompharmacy.com, retrieved 2026].
The origin story is straightforward and still mostly company-described: TOM says it was founded after its pharmacist founder encountered ASC pharmacy work still being run through paper-based processes, and the company now frames its approach as helping ASCs run preventative medication management on structured data [tompharmacy.com, retrieved 2026]. That differentiation, if it proves real in live deployments, rests less on novel infrastructure and more on workflow specificity, compliance adjacency, and credibility with pharmacist users in a tightly regulated care setting [tompharmacy.com, retrieved 2026].
Founder Jon Lim is identified by the company as Founder and CEO, and public materials describe him as a PharmD who leads product strategy, workflow design, software development, customer discovery, partnerships, and implementation [tompharmacy.com, retrieved 2026]. That founder profile is relevant because TOM appears to be selling into a domain where buyer trust and practical pharmacy operations knowledge may matter as much as software breadth, although the public record does not yet show a broader executive bench or named commercial leadership [linkedin.com, retrieved 2026].
On financing, the public picture remains thin. TOM is labeled pre-seed in the available research, but no publicly verified round amount, date, or investor roster was surfaced, and no accelerator participation is confirmed in the cited materials [tompharmacy.com, retrieved 2026]. The business model is presented as SaaS, and the terms page indicates subscription pricing may be adjusted for new subscribers with 30 days’ notice, which at least suggests recurring software revenue rather than project-only consulting economics [tompharmacy.com, retrieved 2026].
Over the next 12 to 18 months, the key questions are practical rather than theoretical: whether TOM can turn pharmacist credibility into named ASC deployments, whether the software becomes embedded in compliance and medication-safety workflows, and whether the company can show proof that replacing paper processes translates into durable purchasing behavior [tompharmacy.com, retrieved 2026]. The public setup is early, but the wedge is legible.
Unconfirmed -- This section relies primarily on company website materials, with limited corroboration from a founder LinkedIn profile.
Taxonomy Snapshot
| Axis | Value |
|---|---|
| Stage | Pre-Seed |
| Business Model | SaaS |
| Industry / Vertical | Healthtech |
| Technology Type | Software (Non-AI) |
| Geography | North America |
| Growth Profile | Venture Scale |
| Founding Team | Solo Founder |
| Funding | Pre-seed |
The Company in Brief
PUBLIC The public record on TOM Pharmacy is thin, but the core outline is straightforward. The company presents itself as an Austin-based business building medication management infrastructure for ambulatory surgery centers, with the website describing a system for ASC medication workflows and the homepage stating it is "Built by a pharmacist" and "Made in Austin, Texas" [tompharmacy.com, retrieved 2026]. The structured company facts identify TOM Pharmacy as founded in 2022, and the public-facing legal name shown on the site is TOM Pharmacy Consulting LLC [tompharmacy.com, retrieved 2026].
The founding story, as disclosed by the company, starts from a pharmacy operations problem rather than a consumer health use case. TOM says it was built to help ASCs run preventative medication management on structured data, with a product angle centered on replacing paper-based logs and related operational processes with pharmacist-oriented software [tompharmacy.com, retrieved 2026]. Public materials also identify Jon Lim as Founder and CEO, and the company frames the business as purpose-built for pharmacy professionals working in or alongside ambulatory surgery centers [tompharmacy.com, retrieved 2026].
Chronologically, the few visible milestones are early and mostly company-reported. com, retrieved 2026]. No public funding round, accelerator affiliation, or customer deployment milestone was confirmed in the source set used for this section, which leaves TOM looking like an early product-in-market effort still defining its public footprint [tompharmacy.com, retrieved 2026].
Unconfirmed -- This section relies primarily on company website disclosures, with no independent Crunchbase or state filing corroboration provided in the source set.
What They Have Built
Product Surface
MIXED The public record supports a narrow but fairly clear picture of what TOM is building. On its website, the company describes TOM MMS as "Medication Management for Ambulatory Surgery Centers" and says it provides "tools, knowledge, and community for pharmacy," with the software positioned around ASC medication workflows rather than a consumer adherence product [tompharmacy.com, retrieved 2026]. The About and Contact pages are more specific about the operating context, stating that TOM helps ASCs run preventative medication management on structured data and inviting centers to request a demo of a medication management system for their ASC [tompharmacy.com, retrieved 2026].
The feature set visible on the homepage is practical and compliance-oriented. The interface shown on the site includes a dashboard, controlled substance log, temperature and humidity logs, a pharmacist verification queue, a compliance score, and a diversion risk view, which suggests the initial product is aimed at replacing paper logs and manual pharmacy operations inside surgery centers with a pharmacist-facing workflow layer [tompharmacy.com, retrieved 2026]. That framing is consistent with the company blog, which repeatedly centers CMS survey preparation, crash-cart accountability, and temperature monitoring as recurring ASC pharmacy pain points, although the blog posts should be read as domain positioning rather than proof of software adoption or technical capability beyond the interface elements shown [tompharmacy.com, retrieved 2026].
Technology Posture
MIXED There is very little verified public evidence on the underlying stack, deployment model, integrations, or data architecture, so any technical reading has to stay close to what the company itself shows. The strongest public signal is that TOM appears to be purpose-built software for pharmacist users in ambulatory surgery settings, with structured operational records at the center of the workflow, rather than a broad hospital IT platform or an AI-led decision tool [tompharmacy.com, retrieved 2026]. The public materials do not confirm EHR connectivity, remote monitoring, predictive analytics, or regulatory certifications, and none should be inferred from the presence of logs, scores, or risk labels alone [tompharmacy.com, retrieved 2026].
One small commercial detail is visible in the terms: TOM Pharmacy Consulting LLC reserves the right to adjust pricing for new subscribers with 30 days' notice, which at minimum indicates a subscription-based software motion rather than one-off consulting only [tompharmacy.com, retrieved 2026]. Even so, the current evidence base is still company-only. There is no verified demo transcript, no third-party implementation case study, and no public technical documentation that would allow a firmer read on reliability, interoperability, or depth of workflow automation.
Unconfirmed -- This section relies primarily on TOM Pharmacy's own website, terms, contact page, and blog, with no independent public product verification identified.
Market Size and Demand
PUBLIC
The market matters now because ambulatory surgery centers face a tighter compliance burden and a stronger cost case for moving medication operations off paper, but the public record for this specific software niche is still thin [KLAS Research] [tompharmacy.com, retrieved 2026].
The cleanest way to size TOM Pharmacy's opportunity from public evidence is through adjacent categories rather than a direct market estimate. KLAS maintains a category for ambulatory surgery center software solutions, which confirms that ASC software is an established procurement area, though the cited comparison page in the source set does not provide a market size figure [KLAS Research]. TOM's own positioning narrows the wedge further, from general ASC software to medication management for surgery centers, with workflow modules such as controlled-substance logs, temperature and humidity logs, pharmacist verification queues, compliance scoring, and diversion risk surfacing on the product page [tompharmacy.com, retrieved 2026]. That suggests a smaller initial serviceable market than broad ASC practice management, but one with a more explicit compliance and pharmacist workflow owner.
A comparable way to think about demand is to start from the operational problem rather than a headline TAM. TOM's public blog content centers on CMS survey preparation, crash cart medication accountability, and temperature monitoring best practices for ASC pharmacies, all of which point to recurring, documentation-heavy tasks that are poorly suited to paper logs as organizations scale across rooms, shifts, and staff handoffs [tompharmacy.com, retrieved 2026]. If that problem is persistent, the adoption trigger is less discretionary digitization and more audit readiness, staff time recovery, and controlled-substance oversight.
| Market lens | Public read-through for TOM | Source |
|---|---|---|
| ASC software category | Confirms established software buying behavior in ambulatory surgery centers, but no sizing figure in cited source set | [KLAS Research] |
| Medication dispensing / pharmacy software (analogous market) | Indicates a broader existing software ecosystem around medication workflows, though not ASC-specific | [FindAlternatives, 2026] |
| Specialty pharmacy management platforms (adjacent market) | Shows neighboring workflow software categories for pharmacy operations, but different end market and buyer set | [IntuitionLabs, retrieved 2026] |
The practical takeaway is that TOM appears to sit in a narrow but intelligible slice between ASC operations software and pharmacy workflow systems. That can be attractive if the company is solving a sharp compliance problem, but public evidence does not yet support a precise TAM, SAM, or SOM estimate.
Several demand drivers are visible even without a quantified market model. The first is regulatory exposure. TOM's own educational materials emphasize CMS survey preparation and pharmacy-related compliance inside ambulatory surgery centers, implying that inspection readiness is not a peripheral issue but a budgeted operating concern for the target customer [tompharmacy.com, retrieved 2026]. The second is workflow formalization. Features shown publicly, including pharmacist verification queues, compliance scores, and diversion risk, suggest that the product is built to turn dispersed pharmacy tasks into auditable structured records rather than informal local processes [tompharmacy.com, retrieved 2026].
There is also a labor and specialization angle. TOM is founded by a PharmD and describes the system as one pharmacists use to manage ASC medication workflows, which implies a user-level design tuned to pharmacy consultants or pharmacy operators rather than general ASC administrators [tompharmacy.com, retrieved 2026] [LinkedIn, retrieved 2026]. In practical terms, that matters because software adoption in clinical operations often depends less on broad enterprise transformation and more on whether the daily operator sees the system as reducing rework, survey risk, or narcotics accountability burden.
The adjacent and substitute markets are broad enough to matter. General ASC operations platforms, medication dispensing systems, and specialty pharmacy management platforms all sit near TOM's category boundary, even if they do not map directly to its ASC medication-management use case [KLAS Research] [FindAlternatives, 2026] [IntuitionLabs, retrieved 2026]. The nearest substitute may still be the incumbent non-software workflow itself: paper logs, spreadsheets, and consultant-led manual processes. That is strategically relevant because replacing a weakly monetized manual status quo can produce a clear ROI narrative, but it can also lengthen adoption cycles if centers do not yet feel acute pain.
Macro conditions cut both ways. On one side, surgery centers have continued incentive to run lean operations and standardize documentation, which should favor software that reduces administrative overhead around recurring pharmacy checks and records [tompharmacy.com, retrieved 2026]. On the other, healthcare software budgets are crowded, and a niche point solution may need to show fast implementation and low workflow disruption to win. Public materials support the existence of the problem and the shape of the product, but not yet the pace of budget release or category-wide spending growth for this exact segment.
Unconfirmed -- This section relies primarily on company materials for market framing and on adjacent-category public sources without confirmed market size figures for ASC medication management specifically.
Who Else Is Fighting for This
MIXED TOM Pharmacy appears to be positioning itself below the hospital-scale pharmacy software stack and closer to the day-to-day compliance and workflow layer inside ambulatory surgery centers, but the public record is still too thin to map direct rivals with much precision [tompharmacy.com, retrieved 2026].
The cleanest way to frame the field is by segment rather than by one-to-one competitors. On the evidence available, TOM is aimed at ASC medication operations, with public product surfaces that include a dashboard, controlled-substance log, temperature and humidity logs, a pharmacist verification queue, a compliance score, and diversion risk prompts [tompharmacy.com, retrieved 2026]. That places it adjacent to broader ambulatory surgery center software categories tracked by KLAS, while also touching medication-dispensing and pharmacy-management workflows described in vendor roundups from FindAlternatives and IntuitionLabs [KLAS Research, retrieved 2026] [FindAlternatives, 2026] [IntuitionLabs, retrieved 2026]. The practical substitute, at least from TOM's own framing, is still manual process, since the company explicitly presents its software as a replacement for paper logs and pharmacy operating routines inside ASCs [tompharmacy.com, retrieved 2026].
The current edge, if there is one, looks domain-specific rather than scale-based. TOM's public materials repeatedly anchor on pharmacist-built workflow and ASC-specific medication management, and the founder presents himself as a PharmD leading product strategy, workflow design, software development, customer discovery, agency partnerships, and implementation [tompharmacy.com, retrieved 2026] [LinkedIn, retrieved 2026]. That can matter in a narrow compliance-heavy setting where buyers often care less about feature breadth than about whether the software matches how medication checks, logs, and survey preparation actually happen on the ground [tompharmacy.com, retrieved 2026]. The durability of that advantage is less certain, because there is no public evidence yet of proprietary data, named channel partners, customer lock-in, or a funded go-to-market engine that would make the wedge hard for a better-capitalized vendor to copy [tompharmacy.com, retrieved 2026] [NFX, 2026].
The exposure is easier to see than the moat. KLAS's ambulatory surgery center software comparison suggests the buyer already faces established vendors at the facility-software layer, and medication-dispensing or pharmacy-management lists indicate adjacent vendors can approach the same account from a broader platform position [KLAS Research, retrieved 2026] [FindAlternatives, 2026] [IntuitionLabs, retrieved 2026]. If an incumbent ASC software provider or a pharmacy-management platform offers even adequate logging, compliance, and verification workflows as part of a larger suite, TOM could be forced to win on implementation quality and clinical credibility rather than product breadth. That is a workable entry point, but it is also a perishable one if procurement consolidates toward bundled systems.
Over the next 18 months, the most plausible scenario is not winner-take-all but account-level sorting by buyer preference. TOM is the likely winner if ASC pharmacists and consultants continue to choose purpose-built tools that mirror their existing medication governance work and reduce paper-based compliance burden without a full system replacement [tompharmacy.com, retrieved 2026]. The likely loser if bundled procurement becomes the default is TOM itself, because the public record does not yet show the distribution, financing, or installed base needed to outmuscle multi-module incumbents in a suite sale [tompharmacy.com, retrieved 2026] [KLAS Research, retrieved 2026]. Conversely, the incumbent cohort tracked by KLAS would be better positioned if buyers prioritize consolidation over specialist depth, although the sources here do not identify a single named vendor that can be cleanly designated as TOM's primary direct rival [KLAS Research, retrieved 2026].
Unconfirmed -- This section relies primarily on company materials, with adjacent-category context from KLAS Research and vendor roundup sources rather than confirmed direct competitor matches.
Opportunity
PUBLIC
The prize here is straightforward: if TOM Pharmacy becomes the operating system for medication compliance and workflow inside ambulatory surgery centers, a narrow pharmacy tool could mature into infrastructure that sits in the daily control layer of a large, regulated care setting [tompharmacy.com, retrieved 2026].
The most credible upside case starts with the fact pattern the company itself has chosen to foreground. TOM is not positioning as a general consumer medication app or a broad hospital platform. Its public materials describe a purpose-built system for ambulatory surgery centers, with product surfaces that map to recurring operational tasks: dashboarding, controlled-substance logs, temperature and humidity logs, pharmacist verification queues, compliance scoring, and diversion risk [tompharmacy.com, retrieved 2026]. That focus matters because ASC pharmacy work is repetitive, compliance-sensitive, and still described by the company as burdened by paper logs and manual processes, which makes workflow software a plausible insertion point rather than a speculative one [tompharmacy.com, retrieved 2026]. If a pharmacist-built product can become the default record of daily medication operations in that setting, the outcome is larger than a point solution.
The route to scale would still depend on turning a narrow wedge into standard operating infrastructure. Public evidence suggests TOM is trying to do that by pairing software with domain content and professional positioning, including ASC-focused compliance articles and direct demo calls for its medication management system [tompharmacy.com, retrieved 2026]. That does not prove adoption, but it does show an attempt to own a specific workflow and buyer conversation, which is the right shape of early motion for vertical software in regulated care.
| Scenario | What happens | Catalyst | Why it's plausible |
|---|---|---|---|
| ASC compliance system of record | TOM becomes the default software layer for medication logs, pharmacist review, and survey preparation inside independent and regional ASC settings | A small number of referenceable ASC deployments convert the product from demoable software into an auditable operating record | The public product already centers on compliance-linked workflows such as CS logs, environmental logs, verification queues, and CMS-relevant pharmacy operations [tompharmacy.com, retrieved 2026] |
| Pharmacist-led network distribution | TOM wins through consultant and pharmacist channels rather than top-down health system IT sales, using a pharmacist-to-pharmacist motion to standardize workflows across multiple ASC clients | Agency partnerships or consultant-led implementations create repeatable distribution into centers that share similar pharmacy pain points | Jon Lim's public profile says he leads customer discovery, agency partnerships, implementation, and pharmacy workflow design, which fits a services-adjacent software wedge at this stage [linkedin.com, retrieved 2026] |
| Structured data layer for adjacent modules | TOM expands from logs and verification into broader medication governance, analytics, and recurring operational tooling once structured workflow data is captured | Product expansion from recordkeeping into analytics, benchmarking, and risk management raises switching costs | The company explicitly says it helps ASCs run preventative medication management on structured data, which implies an ambition beyond digitizing a single paper form [tompharmacy.com, retrieved 2026] |
What would compound here is not a consumer network effect, but workflow entrenchment. If TOM is adopted for daily logging, verification, and compliance preparation, each additional process moved into the system should make it harder to revert to fragmented paper records or spreadsheet-based oversight [tompharmacy.com, retrieved 2026]. The company is already presenting multiple related product surfaces rather than a one-feature tool, and its public blog content is tightly aligned to the same ASC pharmacy pain points the product appears to address, which suggests an early attempt to bind education, workflow design, and software into one distribution loop [tompharmacy.com, retrieved 2026]. In the strongest version of that loop, content drives demos, demos drive workflow adoption, workflow adoption generates structured operational data, and that data supports adjacent modules such as compliance scoring or diversion monitoring.
The size of the win is difficult to quantify from public evidence because no independent market sizing, revenue, or deployment counts are confirmed in the source set. Even so, the shape of the upside is intelligible. If TOM were to become a recognized software standard for medication operations across a meaningful share of U.S. ambulatory surgery centers, the company could resemble a high-retention vertical SaaS asset with compliance adjacency rather than a niche consulting tool (scenario, not a forecast) [tompharmacy.com, retrieved 2026]. The public record does not support a precise valuation range today, but the strategic value would come from controlling a regulated workflow, owning structured pharmacy data, and sitting close to inspection, accountability, and patient-safety processes that customers are unlikely to treat as optional [tompharmacy.com, retrieved 2026].
Unconfirmed -- This section relies primarily on company website materials and founder LinkedIn statements, with no independent public confirmation of customers, deployments, financing, or market size [tompharmacy.com, retrieved 2026] [linkedin.com, retrieved 2026].
Sources
From the public record
[tompharmacy.com, retrieved 2026] TOM Pharmacy | Tools, knowledge, and community for pharmacy | https://www.tompharmacy.com/
[linkedin.com, retrieved 2026] Jon Lim - PharmD Founder, TOM Pharmacy | https://www.linkedin.com/in/tomrx
[KLAS Research] Ambulatory Surgery Center Solutions Software Product Ranking Comparison | https://klasresearch.com/compare/ambulatory-surgery-center-solutions/334
[FindAlternatives, 2026] Best Medication Dispensing Software , Top Tools 2026 | https://findalternatives.net/categories/medication-dispensing
[IntuitionLabs, retrieved 2026] Comparing Top 10 Specialty Pharmacy Management Platforms | IntuitionLabs | https://intuitionlabs.ai/articles/specialty-pharmacy-management-platforms
[NFX, 2026] Top 2026 Pharmaceuticals Pre-Seed Investors | https://signal.nfx.com/investor-lists/top-pharmaceuticals-pre-seed-investors
Articles about TOM Pharmacy
- A Pharmacist-Built System Replaces Paper Logs for Surgical Centers — Founder Jon Lim built the software after seeing consultants rely on paper. Now he's betting ASCs will pay for pharmacist-oriented compliance.